BRCA2 and breast carcinoma: Their results found that RRSO is not associated with a significant reduction in the overall primary breast cancer (PBC) or contralateral breast cancer (CBC) risk in BRCA1 and BRCA2 carriers combined or in BRCA1 carriers alone.